HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jason C Yam Selected Research

1-phenyl-3,3-dimethyltriazene (PDT)

1/2023Cost-effectiveness analysis of myopia management: A systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jason C Yam Research Topics

Disease

22Myopia
03/2024 - 01/2019
4Macular Degeneration (Age-Related Maculopathy)
05/2024 - 04/2022
4Glaucoma
11/2023 - 01/2022
3Astigmatism
11/2023 - 12/2022
3Neoplasms (Cancer)
01/2023 - 12/2020
2Dry Eye Syndromes (Dry Eye Syndrome)
11/2023 - 04/2022
2Graves Ophthalmopathy
11/2023 - 04/2022
2Uveitis
11/2023 - 04/2022
2Cataract (Cataracts)
01/2023 - 04/2022
2Diabetic Retinopathy (Retinopathy, Diabetic)
01/2023 - 04/2022
2Retinoblastoma (Glioblastoma, Retinal)
04/2022 - 10/2021
1Angle-Closure Glaucoma (Glaucoma, Angle Closure)
03/2024
1Conjunctivitis
11/2023
1Atrophy
11/2023
1Retinal Degeneration
01/2023
1Retinal Diseases
01/2023
1Photophobia (Light Sensitivity)
01/2023
1Corneal Injuries
01/2023
1Inflammation (Inflammations)
11/2022
1Necrosis
11/2022
1Alzheimer Disease (Alzheimer's Disease)
11/2022
1Dementia (Dementias)
11/2022
1Vitamin D Deficiency
04/2022
1Orbital Cellulitis
01/2022
1Hemorrhage
01/2022
1Genomic Instability
10/2021
1Ganglion Cysts (Ganglion)
09/2021
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
09/2021
1Eye Diseases (Eye Disease)
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Obesity
01/2021
1Amblyopia (Lazy Eye)
01/2020
1Birth Weight (Birth Weights)
12/2019
1AIDS-Related Complex (ARC)
01/2019
1Refractive Errors (Refractive Error)
01/2019

Drug/Important Bio-Agent (IBA)

17AtropineFDA LinkGeneric
03/2024 - 01/2019
7Ophthalmic Solutions (Eye Drops)IBA
11/2023 - 01/2019
7Retinaldehyde (Retinal)IBA
11/2023 - 01/2020
2Tobacco Smoke Pollution (Passive Smoking)IBA
01/2023 - 12/2019
2A-factor (Streptomyces)IBA
12/2022 - 01/2021
2ORALIT (ORS)IBA
12/2022 - 01/2019
2Vitamin DFDA LinkGeneric
04/2022 - 01/2019
1Interleukin-6 (Interleukin 6)IBA
03/2024
1NucleotidesIBA
03/2024
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2023
1Interleukin-8 (Interleukin 8)IBA
11/2023
1Ranibizumab (Lucentis)FDA Link
01/2023
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2023
1KH902 fusion proteinIBA
01/2023
1Mydriatics (Cycloplegics)IBA
01/2023
1Indicators and Reagents (Reagents)IBA
11/2022
1Complement Factor H (Factor H)IBA
11/2022
1Retinoblastoma ProteinIBA
10/2021
1PoisonsIBA
10/2021
1Etoposide (VP 16)FDA LinkGeneric
10/2021
1Type II DNA Topoisomerases (Topoisomerase II)IBA
10/2021
1cone rod homeobox proteinIBA
10/2021
1DNA (Deoxyribonucleic Acid)IBA
10/2021
1olaparibIBA
10/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2021
1Biomarkers (Surrogate Marker)IBA
09/2021
1hydroxide ionIBA
01/2019
116S Ribosomal RNAIBA
01/2019

Therapy/Procedure

4Therapeutics
11/2023 - 01/2019
2Contact Lenses
11/2023 - 11/2023
1Traction
05/2024
1Retreatment
03/2024
1Aftercare (After-Treatment)
03/2024
1Hydrophilic Contact Lenses (Hydrophilic Contact Lens)
11/2023
1Lenses
11/2023
1Eyeglasses (Spectacles)
11/2023
1Photochemotherapy (Photodynamic Therapy)
01/2023
1Refractive Surgical Procedures
01/2023
1Drug Therapy (Chemotherapy)
01/2022
1Radiotherapy
01/2021
1Brachytherapy
12/2020